Summit Financial Strategies’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
MGP
Summit Financial Strategies's MDT Position: Q2 2026 in Review
Summit Financial Strategies sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,428 shares — an estimated $210K sold.
Summit Financial Strategies first reported a position in MDT in Q4 2017 and held it in 21 quarters. The position peaked at $431K in Q3 2021. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Summit Financial Strategies reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
- Summit Financial Strategies sold 2,428 Medtronic shares in Q2 2026, an estimated $210K.
- Summit Financial Strategies first reported a position in Medtronic in Q4 2017 and held it in 21 quarters.
- Summit Financial Strategies's Medtronic position peaked at $431K in Q3 2021.
- 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Summit Financial Strategies's 13F filing for Q2 2026, filed 24 Jul 2026.